Universitas Gadjah Mada (UGM) and PT Etana Biotechnologies Indonesia signed a Memorandum of Understanding to initiate collaborative biotechnology research, focusing on biopharmaceutical development and biologic medicines innovation.
UGM and PT Etana Biotechnologies Strengthen Research Collaboration in Biotechnology
Key Details
The partnership between UGM and PT Etana Biotechnologies aims to strengthen biopharmaceutical research capabilities in Indonesia, particularly targeting the development of biologic medicines. The MoU was signed at the UGM campus and establishes a framework for joint research initiatives.
The collaboration will encompass joint research projects, student internship programs, and sharing of equipment and expertise between the academic institution and the biopharmaceutical company. Both organizations expect the partnership to generate significant breakthroughs in health sciences while enhancing Indonesia’s biotechnology sector capabilities.
Quotes & Reactions
UGM’s Vice-Rector for Research and Innovation, Prof. Dr. Ir. Panut Mulyono, M.Eng., expressed enthusiasm for the biotechnology research collaboration. “Through this collaboration, we hope to enhance Indonesia’s capability in the biotechnology sector and create innovations that can improve public health,” he remarked.
Mulyono emphasized UGM’s commitment as an educational institution to contributing research that can be applied for societal welfare.
PT Etana Biotechnologies president director Hendra Setiawan emphasized the importance of partnerships in advancing the biopharmaceutical industry. According to Setiawan, the collaboration with UGM will facilitate access to cutting-edge research and development capabilities.
Background & Context
PT Etana Biotechnologies is recognized as a leading biopharmaceutical company specializing in developing biologic medicines in Indonesia. The company has established itself as a key player in the nation’s biotechnology landscape.
UGM continues expanding its research partnerships with industry leaders to bridge academic research with practical applications. The university’s commitment to biotechnology advancement aligns with national healthcare improvement goals.
What’s Next
Both parties remain optimistic that the collaboration will contribute significantly to Indonesia’s biopharmaceutical capability development. The partnership is expected to pave the way for future research initiatives that could impact public health outcomes nationwide.
